Holen Sie sich die Stockscreener-App
11.60
5.94%
0.65
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | -0.44 | - | - |
Operating Expenses
|
5.49%
42.99
|
45.48 | 44.80 | 37.60 | 62.76 |
| Operating Income/Loss |
5.49%
-42.99
|
-45.48 | -45.24 | -37.60 | -62.76 |
| Income/Loss From Continuing Operations Before Tax |
5.91%
-37.34
|
-39.69 | -39.18 | -32.21 | -58.14 |
| Income/Loss From Continuing Operations After Tax |
46.07%
-37.34
|
-25.56 | -39.18 | -32.21 | -58.14 |
|
Net Income/Loss
|
46.07%
-37.34
|
-25.56 | -39.18 | -32.21 | -58.14 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
89.09%
-0.192
|
-1.76 | - | - | -0.179 |
| Basic Average Shares |
10,141%
43.01
|
0.42 | 42.73 | 39.95 | 40.68 |
| Diluted Average Shares |
10,141%
43.01
|
0.42 | 42.73 | 39.95 | 40.68 |
| Basic Earnings Per Share |
59.26%
-0.86
|
-0.54 | -0.91 | -0.82 | -1.42 |
| Diluted Earnings Per Share |
59.26%
-0.86
|
-0.54 | -0.91 | -0.82 | -1.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):